Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
EnPlusOne Biosciencesenplusonebio.com · Low evidenceEnPlusOne Biosciences provides a flexible enzymatic platform for RNA synthesis, enabling unrestricted scale and access to novel RNA modifications. Their technology overcomes current manufacturing limitations by supporting high-purity long RNA and a broader design space beyond the 20 modifications accessible through chemical synthesis.
Parse Score